- Home
- MGRX vs BFRI Comparison
MGRX vs BFRI Comparison
Compare MGRX & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MGRX | BFRI |
|---|---|---|
| Founded | 2021 | 1997 |
| Country | United States | United States |
| Employees | N/A | 94 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7M | 9.5M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | MGRX | BFRI |
|---|---|---|
| Price | $0.35 | $0.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.75 |
| AVG Volume (30 Days) | ★ 10.0M | 115.3K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.17 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $456,021.00 | N/A |
| Revenue This Year | N/A | $11.67 |
| Revenue Next Year | N/A | $19.80 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.27 | $0.54 |
| 52 Week High | $2.88 | $1.18 |
Technical Indicators
Market Signals| Indicator | MGRX | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 43.98 | 65.88 |
| Support Level | $0.32 | $0.78 |
| Resistance Level | $0.47 | $1.06 |
| Average True Range (ATR) | 0.07 | 0.07 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 30.11 | 95.03 |
Price Performance
Historical ComparisonAbout MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.